Genetic studies have shown that downregulation of NHEJ proteins KU70/KU80 or downregulation or inactivation of DNA-PKcs rescues the cisplatin sensitivity of FA defective cells. The gene discussed is XRCC6; the disease is Friedreich ataxia.